Related Experiment Video

Updated: Jul 1, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

507

Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis

Joana Gouveia1, Maria Alexandra Rodrigues2, Iolanda Fernandes3

  • 1Serviço de Imunoalergologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.

Acta Medica Portuguesa
|March 2, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
COVID-19/immunologyCOVID-19 VaccinesMastocytosisMessengerRNASystemic/immunology

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.4K

Related Concept Videos